MedTrace Logo

Current Use in Intensive Care Units by Intensivists of Antihypertensive Drugs

NCT04924946 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-06-14

No results posted yet for this study

Summary

Multicenter, prospective and observational study of practices and impacts of the use of antihypertensive therapies in intensive medicine and intensive care

Conditions

  • Antihypertensive Drugs in ICU

Interventions

OTHER

Inventory of prescribing habits and detect any differences in efficacy and tolerance of antihypertensive drugs

* Time to monitor blood pressure values in target targets * Need for administration of another antihypertensive drug * Disappearance of organ failure attributable to hypertension * Weaning from an extra-renal purification * Weaning from mechanical ventilation * Improved kidney function * Iatrogenic hypotension * Need for suspension of treatment * Other side effect

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2019-06-01
Completion
2021-08-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04924946 on ClinicalTrials.gov